2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Revenue | $1.7B | $2B | $2.2B | $2.5B | $2.9B |
Cost of Revenue | $292M | $359M | $404M | $447M | $514M |
Gross Profit | $1.4B | $1.7B | $1.8B | $2.1B | $2.3B |
Gross Profit % | 83% | 82% | 82% | 82% | 82% |
R&D Expenses | $101M | $112M | $107M | $132M | $159M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Net Income | $602M | $726M | $871M | $1.1B | $1.1B |
Dep. & Amort. | $111M | $134M | $142M | $159M | $206M |
Def. Tax | -$56M | -$111M | $36M | -$15M | $14M |
Stock Comp. | $51M | $55M | $58M | $72M | $95M |
Chg. in WC | $52M | $60M | -$19M | $2.5M | $73M |
2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $1.3B | $1.4B | $994M | $458M | $406M |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $1.3B | $1.4B | $994M | $458M | $406M |
Receivables | $559M | $665M | $663M | $840M | $821M |
Inventory | $20M | $6M | $37M | $0 | $0 |
MSCI reported strong Q1 2025 financials: organic revenue growth of 10%, adjusted EBITDA growth of 11%, and adjusted EPS growth of nearly 14%; $275M in share repurchases completed in Q1 and through April 21.
Operating metrics remained robust with a retention rate over 95%, organic subscription run rate growth of 8%, and asset-based fee revenue growth of 18%, driven by strong ETF and non-ETF AUM linked to MSCI indices.
Notable client segment performance included 14% subscription run rate growth with hedge funds, 9% with banks and broker dealers, 15% with wealth managers, and 12% with asset owners; recurring net new sales in private capital solutions grew by 24%.
The company highlighted a new partnership with Moody’s to develop independent credit risk assessments for private credit, and noted continued momentum in custom indices and climate-related products; climate-linked AUM grew by 50% to $387B.
Guidance remains unchanged; management is prepared to flex expenses based on market conditions, expects Q2 effective tax rate (ex-discrete items) of 19–21%, and sees continued resilience due to high recurring revenue (98%), strong margins, and mission-critical product demand amid market uncertainty.